Vialinin A

• CAT Number: I011069
• CAS Number: 858134-23-3
• Molecular Formula: C34H26O8
• Molecular Weight: 562.57
• Purity: ≥95%
• Synonyms: 1,1/’-(4,4/’/’,5/’,6/’-Tetrahydroxy[1,1/’:4/’,1/’/’-terphenyl]-2/’,3/’-diyl) benzeneacetic acid ester
• Target: Deubiquitinase
• Solubility: Soluble to 20 mM in DMSO
• Storage: Store at -20C
• IUPAC Name: [3,4-dihydroxy-2,5-bis(4-hydroxyphenyl)-6-(2-phenylacetyl)oxyphenyl] 2-phenylacetate
• InChI: InChI=1S/C34H26O8/c35-25-15-11-23(12-16-25)29-31(39)32(40)30(24-13-17-26(36)18-14-24)34(42-28(38)20-22-9-5-2-6-10-22)33(29)41-27(37)19-21-7-3-1-4-8-21/h1-18,35-36,39-40H,19-20H2
• InChIKey: NOJUKCRPSUMHQQ-UHFFFAOYSA-N
• SMILES: C1=CC=C(C=C1)CC(=O)OC2=C(C(=C(C(=C2C3=CC=C(C=C3)O)O)O)C4=CC=C(C=C4)O)OC(=O)CC5=CC=CC=C5

Vialinin A(CAT: I011069) is a potent and selective inhibitor of tumor necrosis factor-alpha (TNF-α) production, with significant anti-inflammatory properties. It is widely used in pharmaceutical research to study inflammatory pathways and immune modulation. By suppressing TNF-α signaling, Vialinin A aids in exploring the mechanisms underlying chronic inflammatory diseases, autoimmune disorders, and cancer. This compound is also valuable in investigating oxidative stress and related cellular responses. With its high specificity and efficacy, Vialinin A serves as a critical tool for advancing drug discovery and therapeutic development targeting inflammation and immune regulation.